Barry S. Berman

1.9k total citations · 2 hit papers
12 papers, 1.3k citations indexed

About

Barry S. Berman is a scholar working on Oncology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Barry S. Berman has authored 12 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Genetics and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Barry S. Berman's work include Glioma Diagnosis and Treatment (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Research and Treatments (2 papers). Barry S. Berman is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Research and Treatments (2 papers). Barry S. Berman collaborates with scholars based in United States, Canada and Australia. Barry S. Berman's co-authors include Barbara L. Andersen, Julia H. Rowland, Victoria L. Champion, Mark R. Somerfield, Jimmie C. Holland, Ann H. Partridge, Jessie Gruman, Robert J. DeRubeis, Mary Jane Massie and Kate Bak and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Therapy and Annals of Surgical Oncology.

In The Last Decade

Barry S. Berman

12 papers receiving 1.3k citations

Hit Papers

Screening, Assessment, and Care of Anxiety and Depressive... 2014 2026 2018 2022 2014 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry S. Berman United States 9 765 302 281 234 163 12 1.3k
Judith Hurley United States 24 1.1k 1.4× 150 0.5× 330 1.2× 441 1.9× 63 0.4× 74 2.3k
Nina N. Sanford United States 21 474 0.6× 402 1.3× 103 0.4× 134 0.6× 59 0.4× 113 1.2k
T.J. Priestman United Kingdom 20 580 0.8× 349 1.2× 151 0.5× 126 0.5× 68 0.4× 35 1.3k
Sue Ashley United Kingdom 18 378 0.5× 429 1.4× 198 0.7× 329 1.4× 124 0.8× 27 1.6k
Talya Salz United States 17 906 1.2× 247 0.8× 245 0.9× 354 1.5× 139 0.9× 46 1.4k
Glenn Jones Canada 23 644 0.8× 382 1.3× 184 0.7× 292 1.2× 99 0.6× 69 2.0k
Peg Esper United States 18 757 1.0× 702 2.3× 219 0.8× 161 0.7× 52 0.3× 30 1.8k
Melisa L. Wong United States 20 728 1.0× 599 2.0× 157 0.6× 164 0.7× 86 0.5× 68 1.4k
Stephen P. Richman United States 21 1.1k 1.4× 385 1.3× 294 1.0× 325 1.4× 38 0.2× 67 1.9k
Young Seon Hong South Korea 24 790 1.0× 208 0.7× 227 0.8× 579 2.5× 177 1.1× 75 1.8k

Countries citing papers authored by Barry S. Berman

Since Specialization
Citations

This map shows the geographic impact of Barry S. Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry S. Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry S. Berman more than expected).

Fields of papers citing papers by Barry S. Berman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry S. Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry S. Berman. The network helps show where Barry S. Berman may publish in the future.

Co-authorship network of co-authors of Barry S. Berman

This figure shows the co-authorship network connecting the top 25 collaborators of Barry S. Berman. A scholar is included among the top collaborators of Barry S. Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry S. Berman. Barry S. Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Andersen, Barbara L., Christina Lacchetti, Kimlin Ashing, et al.. (2023). Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 41(18). 3426–3453. 105 indexed citations breakdown →
2.
Wong, Sandra L., Mark B. Faries, Erin B. Kennedy, et al.. (2017). Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Annals of Surgical Oncology. 25(2). 356–377. 106 indexed citations
3.
Wong, Sandra L., Mark B. Faries, Erin B. Kennedy, et al.. (2017). Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 36(4). 399–413. 168 indexed citations
4.
Chin, Joseph L., R. Bryan Rumble, Marisa Kollmeier, et al.. (2017). Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update. Journal of Clinical Oncology. 35(15). 1737–1743. 123 indexed citations
5.
Попов, Е. Г., et al.. (2014). Mesenteric vein thrombosis caused by secondary polycythaemia from AndroGel. BMJ Case Reports. 2014. bcr2014206023–bcr2014206023. 6 indexed citations
6.
Andersen, Barbara L., Robert J. DeRubeis, Barry S. Berman, et al.. (2014). Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation. Journal of Clinical Oncology. 32(15). 1605–1619. 531 indexed citations breakdown →
7.
Vukelja, Svetislava J., Stephen P. Anthony, James C. Arseneau, et al.. (2007). Phase 1 study of escalating-dose OncoGel® (ReGel®/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions. Anti-Cancer Drugs. 18(3). 283–289. 74 indexed citations
8.
Nemunaitis, John, Neil Senzer, Casey Cunningham, et al.. (2006). Phase I Trial of Sequential Administration of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small-Cell Lung Cancer. Molecular Therapy. 13(6). 1185–1191. 53 indexed citations
9.
Senzer, Neil, et al.. (2005). Irofulven Demonstrates Clinical Activity Against Metastatic Hormone-Refractory Prostate Cancer in a Phase 2 Single-Agent Trial. American Journal of Clinical Oncology. 28(1). 36–42. 27 indexed citations
10.
Vukelja, Svetislava J., Wolfram E. Samlowski, James C. Arseneau, et al.. (2004). A dose-escalation, Phase I study of a depot formulation of paclitaxel administered intralesionally in end-stage cancer patients with solid malignant tumors. Journal of Clinical Oncology. 22(14_suppl). 2131–2131. 1 indexed citations
11.
Vukelja, Svetislava J., Wolfram E. Samlowski, James C. Arseneau, et al.. (2004). A dose-escalation, Phase I study of a depot formulation of paclitaxel administered intralesionally in end-stage cancer patients with solid malignant tumors. Journal of Clinical Oncology. 22(14_suppl). 2131–2131. 1 indexed citations
12.
Berman, Barry S., Peter T. Silberstein, Marc L. Citron, et al.. (1998). Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study. European Journal of Pain. 2(3). 239–249. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026